Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BMP-2-inducible protein kinase (BMP2K)
- Target
- BMP2K
- Molecular classification
- Enzyme, Serine/threonine protein kinase, Numb-associated kinase (NAK) family
01
Overview
BMP-2-inducible protein kinase (BMP2K) is a serine/threonine protein kinase implicated in the regulation of osteoblast differentiation. It is part of the Numb-associated kinase (NAK) family, which have roles in diverse cellular processes including endocytosis and modulation of developmental signaling pathways. BMP2K expression is upregulated during BMP-2-induced differentiation, and the protein is thought to act as a negative regulator in bone formation by attenuating osteoblast differentiation. There are at least two transcript variants encoding different isoforms. Structural studies have confirmed its kinase fold and suggest potential druggability, but no selective therapeutic agents are currently approved that specifically target BMP2K. Its role in disease remains underexplored, but related NAK kinases are linked to cancer, neurodegeneration, and viral infection.
- Other names
- BIKEDKFZp434K0614HRIHFB2017BMP2KBMP-2-inducible kinase
02
Mechanism of action
Putative: kinase inhibitors (inhibiting BMP2K or related NAK kinases can block phosphorylation-dependent signaling). No marketed drugs with an explicit mechanism targeting only BMP2K noted; investigational compounds targeting the NAK family exist.
03
Biological functions
Osteoblast differentiation regulationAttenuation of osteoblast differentiation in response to BMP-2Likely modulation of receptor-mediated endocytosis and Notch pathway (NAK family context)
04
Disease associations
Cancer (notably, NAK kinases are linked with some cancers such as prostate cancer)Ovarian cystic teratomaMature teratoma of the ovaryPotential roles in neurodegenerative diseases and infection (based on broader NAK family roles)
05
Safety considerations
Not specifically characterized for BMP2K; general kinase inhibitor challenges may include off-target effects and impact on essential differentiation pathways
06
Interacting drugs
No specific drugs uniquely listed as clinically used BMP2K inhibitors; kinase inhibitors for NAK family may have cross-reactivity
07
Biomarkers
No widely used clinical biomarkers for BMP2K; tissue and lineage expression varies
Beyond the preview
Go deeper on BMP-2-inducible protein kinase (BMP2K).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BMP-2-inducible protein kinase (BMP2K).